<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788680</url>
  </required_header>
  <id_info>
    <org_study_id>UVienna21</org_study_id>
    <nct_id>NCT04788680</nct_id>
  </id_info>
  <brief_title>Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function</brief_title>
  <official_title>Assessment of the Effects of Non-calorie Sweeteners on Gut Barrier and Inflammatory Markers Compared to Those of Sugars in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to determine the effect of non-nutritive sweeteners on&#xD;
      intestinal barrier function and inflammatory markers in healthy subjects in comparison to&#xD;
      mono- and disaccharides.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the intervention study normal weight participants will receive beverages sweetened with&#xD;
      non-nutritive sweeteners, mono- and disaccharides for a defined number of days. Before and&#xD;
      after intervention parameters of intestinal barrier function will be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>All participants receive all interventional diets</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in parameters of intestinal barrier function.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in plasma endotoxin levels.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in inflammatory markers.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in IL-6 plasma levels (ng/ml).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in systolic and diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in markers for glucose metabolism.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in fasting glucose (mg/dl) and fasting insulin levels (mU/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in markers for glucose metabolism.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in fasting insulin levels (mU/l).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood lipid levels.</measure>
    <time_frame>1 week</time_frame>
    <description>Changes in triglyceride levels.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Dietary Habits</condition>
  <condition>Endotoxemia</condition>
  <arm_group>
    <arm_group_label>Experimental: Beverage 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a beverage with a defined amount of non-nutritive sweetener.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Beverage 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a beverage with a defined amount of non-nutritive sweetener.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Beverage 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a beverage with a defined amount of monosaccharide.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Beverage 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a beverage with a defined amount of disaccharide.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary intervention 1</intervention_name>
    <description>Participants receive a beverage with a defined amount of non-nutritive sweetener.</description>
    <arm_group_label>Experimental: Beverage 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Intervention 2</intervention_name>
    <description>Participants receive a beverage with a defined amount of non-nutritive sweetener and maltodextrin.</description>
    <arm_group_label>Experimental: Beverage 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Intervention 3</intervention_name>
    <description>Participants receive a beverage with a defined amount of monosaccharide.</description>
    <arm_group_label>Experimental: Beverage 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Intervention 4</intervention_name>
    <description>Participants receive a beverage with a defined amount of disaccharide.</description>
    <arm_group_label>Experimental: Beverage 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No known history of metabolic diseases/disorders&#xD;
&#xD;
          -  BMI &lt;25 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Food allergies or intolerances (esp. fructose intolerance and malabsorption)&#xD;
&#xD;
          -  Chronic disease of the gastrointestinal tract&#xD;
&#xD;
          -  Renal insufficiency&#xD;
&#xD;
          -  Taking drugs affecting lipid or glucose metabolism&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ina Bergheim, Prof. Dr.</last_name>
      <phone>+43 1 4277 54981</phone>
      <email>ina.bergheim@univie.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Anja Baumann, Dr.</last_name>
      <phone>+43 1 4277 54985</phone>
      <email>anja.baumann@univie.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Raphaela Staltner, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Ina Bergheim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

